Vmbook Online ordering

Icons

**General Information about Patch Plus**

* **Company Name:** Patch Plus, Inc.

* **Stock Symbol:** PATCH

* **Exchange:** Nasdaq

* **Industry:** Medical Devices

* **Headquarters:** San Jose, California

**Patch Plus Overview**

Patch Plus is a medical device company that develops and manufactures advanced transdermal drug delivery systems. Its flagship product is the Patch Plus System, a wearable patch that delivers drugs through the skin.

**Earnings and Growth**

* **Revenue:** $12.4 million in 2022, up 25% from 2021

* **Net Income:** $2.2 million in 2022, up 10% from 2021

* **Earnings Per Share (EPS):** $0.10 in 2022, up 11% from 2021

* **Annual Revenue Growth Rate:** 25% over the past 3 years

* **Annual EPS Growth Rate:** 15% over the past 3 years

**Market Capitalization and Valuation**

* **Market Capitalization:** $250 million as of March 8, 2023

* **Price-to-Earnings (P/E) Ratio:** 25x

**Key Metrics**

* **Gross Margin:** 65%

* **Operating Margin:** 15%

* **Net Margin:** 10%

* **Return on Equity (ROE):** 12%

* **Return on Assets (ROA):** 6%

**Growth Drivers**

* Expanding product portfolio

* Increasing adoption of transdermal drug delivery systems

* Partnerships with pharmaceutical companies

* International expansion

**Risks**

* Competition from other transdermal drug delivery companies

* Regulatory challenges

* Manufacturing issues

* Clinical trial failures